CRT 2025

Panel Discussion | Opportunities and Barriers of TMVR

Moderator(s)

• 

  Molly Szerlip, MD

  Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam
  Baylor Scott and White The Heart Hospital Baylor Plano
  Richardson, Texas, United States

  Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Board (Ongoing); Cardiovascular Innovations Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Dee Dee Wang, MD

  Section Head Cardiac Imaging
  NCH Rooney Heart Institute, Michigan, United States

  Disclosure(s): Abbott Vascular,: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Materialise: Consultant (Ongoing)
• 

  Firas Zahr, MD

  Director, Interventional Cardiology
  OHSU

  Disclosure(s): Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

• 

  Carlo Di Mario, MD

  Professor
  University of Florence
  Florence, Toscana, Italy

  Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)
• ME

  Marvin Eng, MD

  Structural Heart Disease Medical Director
  Banner University Medical Center
  Phoenix, Arizona, United States

  Disclosure(s): Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Jaffar M. Khan, MD, PhD

  Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
  St Francis Hospital and Heart Center
  Roslyn, New York, United States

  Disclosure(s): Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Ehud Raanani, MD

  Director of the Cardiothoracic and Vascular Center
  Sheba Medical Center
  Tel Hashomer, HaMerkaz, Israel

  Disclosure(s): Innovalve: Co-Founder (Ongoing)
• 

  Lucy Michelle Safi, DO

  Assistant Professor of Medicine (Cardiology)
  Mount Sinai Hospital
  New York, New York, United States

  Disclosure(s): Abbott Structural Heart, Medtronic, Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Maurice Sarano, MD

  Senior Scientist
  Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ajit Yoganathan, PhD

  Emeritus Regents Professor
  Georgia Institute of Technology
  TUCKER, Georgia, United States

  Disclosure information not submitted.
• 

  Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

  Professor and Clinical Director of Interventional cardiology
  Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)